Premenstual Syndrom. Unspecified condition associated with female genital organs and menstrual cycle
Conditions
Interventions
Intervention 1: Intervention group: saffron, self-made capsule 30 mg, oral, once a day from fourteen to twenty-eight day menstrual cycle for two month. Intervention 2: Control groups: fluoxetine, c
Treatment - Drugs
Intervention group: saffron, self-made capsule 30 mg, oral, once a day from fourteen to twenty-eight day menstrual cycle for two month.
Control groups: fluoxetine, capsule 20 mg, oral, once a day from fourteen to twenty-eight day menstrual cycle for two months.
Sponsors
Vice chancellor for research, Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: informed consent; Eighteen to forty years; regular Menstrual Periods( 35-21 days); Normal cycle (10-3 day); Physical and Mental health; The absence of anemia in the past three months ; Having one or more Symptoms of Premenstrual Syndrome in 2 consecutive cycles; no Pregnancy intention. Exclusion criteria: Underlying disease; Taking other drugs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Masstalgia. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: Vigual Scare.;Abdominal Pain. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: Vigual Scare.;Abdominal Bloat. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: weist size.;Deppretion. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: Test Deppretion Beck.;Anexity. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: Test anxiety Beck. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtefeh Asadi
Sabzevar University of Medical Sciences
Outcome results
None listed